SHCRW (Sharecare) Research & Development: $61.46 Mil (TTM As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHCRW Sharecare Inc SHCRW
12 GF Score
Price $0.09
! 5 Warning Signs
View Full Analysis

What is Sharecare Research & Development?

Sharecare SHCRW 12 Research & Development is $61.46 Mil as of Jun. 2024. GuruFocus rates SHCRW with a GF Score™ of 12/100. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Sharecare's Research & Development for the three months ended in Jun. 2024 was $14.71 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 was $61.46 Mil.

Sharecare  (NAS:SHCRW) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sharecare Research & Development Related Terms

Sharecare Research & Development Historical Data

* Premium members only.

The historical data trend for Sharecare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sharecare Research & Development Chart

Sharecare Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
45.86 44.08 74.44 70.53 70.05

Sharecare Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.04 15.27 16.93 14.54 14.71
SHCRW
12GF Score
Sharecare Inc SHCRW
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sharecare Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $61.46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $61.46 Mil mean?
Sharecare (SHCRW) has a Research & Development of $61.46 Mil as of Jun. 2024. Research and development expense is the total cost for research and development activities. View historical data on Sharecare and its competitors.
Is Sharecare's Research & Development too high?
Sharecare's current Research & Development is $61.46 Mil. Overall, Sharecare has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Sharecare's Research & Development compare to AMWL and SPOK?
Sharecare's Research & Development of $61.46 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Sharecare and its competitors. Sharecare's current Research & Development is $61.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sharecare stock overvalued right now?
Sharecare (SHCRW) has a current Research & Development of $61.46 Mil. The current Research & Development is $61.46 Mil. Sharecare's overall GF Score™ is 12/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Sharecare (SHCRW), the current Research & Development is $61.46 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sharecare Business Description

Address 255 East Paces Ferry Road NE, Suite 700, Atlanta, GA, USA, 30305
Sharecare Inc is a digital healthcare platform company that helps members consolidate and manage various components of their health in one place, regardless of their health journey. Its platform offers an accessible, interactive, personalized and rewarding environment that aims to transform user engagement with healthcare from episodic to everyday. The platform provides a single destination for people, patients and caregivers to access quality and clinically reviewed content; digitally connect with other patients, community members and healthcare professionals; and adopt action plans provided by healthcare professionals from top institutions.
12GF Score

Get the complete analysis for SHCRW

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.09
Price